citalopram

1
Reactions 1108 - 1 Jul 2006 S Citalopram Delirium and extrapyramidal disorders in an elderly patient: case report A 77-year-old woman developed delirium and extrapyramidal disorders during treatment with citalopram for depressive symptoms. The woman was hospitalised for dehydration secondary to antibacterial-associated diarrhoea and had subtle extrapyramidal features including reduced mobility, psychomotor slowing, swallowing difficulty and increased tone with cogwheeling in her left upper limb; she started receiving citalopram 10 mg/day. Over the next 4 days, her condition deteriorated significantly, with markedly worsened extrapyramidal signs and hypoactive delirium. She developed marked bradykinesia and rigid limbs, associated with reduced self-care, monosyllabic speech, and decreased swallowing coordination. She could no longer follow requests. Her deterioration continued, with a reduced consciousness level, sustained ankle clonus with positive Babinski responses, and increased rigidity with cogwheeling. Citalopram was stopped 3 days after it was started, and the woman received lorazepam for possible catatonia. Her liver function tests were mildly elevated, and her C-reactive protein level was 10 mg/L. She was transferred to another hospital for additional investigation and treatment. A brain MRI showed generalised brainstem, cortical and posterior fossa atrophy. Two attempts at lumbar puncture were unsuccessful. Over the next 3 days, dystonic posturing of her upper limbs developed. Her rigidity in both upper limbs continued. Lorazepam was stopped 5 days after it was started. Over the next 7 days, she improved and became more communicative and alert. The tone in her upper limbs remained increased. She received levodopa with no noticeable effect and levodopa was stopped. After 10 days, she was transferred back to the original hospital, where she improved over the next month and became orientated and alert. She communicated freely and had mobility using a low frame under supervision. The increased tone in her upper limbs persisted, but improved. Author comment: "This appears to be a case of a neurotoxic reaction with severe extrapyramidal features (Parkinsonism and dystonia) and delirium probably resulting from citalopram." Thwaites JH, et al. Neurotoxic reaction to citalopram. New Zealand Medical Journal 119: 134-136, No. 1235, 2 Jun 2006 - New Zealand 801067681 1 Reactions 1 Jul 2006 No. 1108 0114-9954/10/1108-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: doanliem

Post on 16-Mar-2017

213 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Citalopram

Reactions 1108 - 1 Jul 2006

SCitalopram

Delirium and extrapyramidal disorders in an elderlypatient: case report

A 77-year-old woman developed delirium andextrapyramidal disorders during treatment with citalopram fordepressive symptoms.

The woman was hospitalised for dehydration secondary toantibacterial-associated diarrhoea and had subtleextrapyramidal features including reduced mobility,psychomotor slowing, swallowing difficulty and increasedtone with cogwheeling in her left upper limb; she startedreceiving citalopram 10 mg/day. Over the next 4 days, hercondition deteriorated significantly, with markedly worsenedextrapyramidal signs and hypoactive delirium. She developedmarked bradykinesia and rigid limbs, associated with reducedself-care, monosyllabic speech, and decreased swallowingcoordination. She could no longer follow requests. Herdeterioration continued, with a reduced consciousness level,sustained ankle clonus with positive Babinski responses, andincreased rigidity with cogwheeling.

Citalopram was stopped 3 days after it was started, and thewoman received lorazepam for possible catatonia. Her liverfunction tests were mildly elevated, and her C-reactive proteinlevel was 10 mg/L. She was transferred to another hospital foradditional investigation and treatment. A brain MRI showedgeneralised brainstem, cortical and posterior fossa atrophy.Two attempts at lumbar puncture were unsuccessful. Over thenext 3 days, dystonic posturing of her upper limbs developed.Her rigidity in both upper limbs continued. Lorazepam wasstopped 5 days after it was started. Over the next 7 days, sheimproved and became more communicative and alert. Thetone in her upper limbs remained increased. She receivedlevodopa with no noticeable effect and levodopa was stopped.After 10 days, she was transferred back to the original hospital,where she improved over the next month and becameorientated and alert. She communicated freely and hadmobility using a low frame under supervision. The increasedtone in her upper limbs persisted, but improved.

Author comment: "This appears to be a case of aneurotoxic reaction with severe extrapyramidal features(Parkinsonism and dystonia) and delirium probably resultingfrom citalopram."Thwaites JH, et al. Neurotoxic reaction to citalopram. New Zealand MedicalJournal 119: 134-136, No. 1235, 2 Jun 2006 - New Zealand 801067681

1

Reactions 1 Jul 2006 No. 11080114-9954/10/1108-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved